مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

918
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PREVALENCE OF ALLOIMMUNIZATION IN MAJOR BETA THALASSEMIA IN NORTHERN IRAN (2010)

Pages

  76-79

Abstract

 Background and Objective: Repeated BLOOD TRANSFUSION is the major treatment for patients with major thalassemia. However due to antigen encounters, it may initiate body reactions, including alloantibodies against red blood cell antigens. This study was done to determine the Prevalence of ALLOIMMUNIZATION in major BETA THALASSEMIA patients in northern Iran.Method: This descriptive - analytic study was carried out on 218 thalassemic patients (100 males and 118 females) with average age of 22.5±7 years in northern Iran during 2010. Each sample was tested for the presence of Alloantibodies including C, Cw, Lea, E, Lua, Leb, K, Jkb, N, P1, D, Jka, M, S, Xga, e, Fya, s, c, Fyb, k, Kpa, Jsb, Lub and Coa.Results: Eighty eight cases (40.4%; 95% CI: 33.9-46.9) were positive for the presence of alloantibodies. Alloantibodies against C, Cw, Lea red blood cell surface antigens were the most prevalent (40%). No significant correlation was found between emergence of alloantibody with the age of initial, frequency and duration of BLOOD TRANSFUSION.Conclusion: ALLOIMMUNIZATION is a common observation in thalassemic patients and should be prevented by transfusing compatible blood.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    KOSARYAN, M., MAHDAVI, M.R., HOJJATI, M.T., & ROSHAN, P.. (2014). PREVALENCE OF ALLOIMMUNIZATION IN MAJOR BETA THALASSEMIA IN NORTHERN IRAN (2010). JOURNAL OF GORGAN UNIVERSITY OF MEDICAL SCIENCES, 16(3 (51)), 76-79. SID. https://sid.ir/paper/78798/en

    Vancouver: Copy

    KOSARYAN M., MAHDAVI M.R., HOJJATI M.T., ROSHAN P.. PREVALENCE OF ALLOIMMUNIZATION IN MAJOR BETA THALASSEMIA IN NORTHERN IRAN (2010). JOURNAL OF GORGAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2014;16(3 (51)):76-79. Available from: https://sid.ir/paper/78798/en

    IEEE: Copy

    M. KOSARYAN, M.R. MAHDAVI, M.T. HOJJATI, and P. ROSHAN, “PREVALENCE OF ALLOIMMUNIZATION IN MAJOR BETA THALASSEMIA IN NORTHERN IRAN (2010),” JOURNAL OF GORGAN UNIVERSITY OF MEDICAL SCIENCES, vol. 16, no. 3 (51), pp. 76–79, 2014, [Online]. Available: https://sid.ir/paper/78798/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button